Search Results for "Bacterial"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Bacterial. Results 161 to 170 of 344 total matches.
Two Neuraminidase Inhibitors for Treatment of Influenza
The Medical Letter on Drugs and Therapeutics • Oct 08, 1999 (Issue 1063)
decreased the incidence of influenza-related complications requiring use
of antibacterial drugs (MIST Study ...
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon.
Dofetilide for Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • May 15, 2000 (Issue 1078)
such as macrolide antibiotics, azole antifungals, protease inhibitors, selective serotonin reuptake inhibitors ...
Dofetilide (Tikosyn - Pfizer), a new methanesulfonamide antiarrhythmic drug, has recently been marketed for oral treatment of atrial fibrillation and flutter.
Drugs that may cause Cognitive Disorders in the Elderly
The Medical Letter on Drugs and Therapeutics • Nov 27, 2000 (Issue 1093)
antibiotics Confusion Very high doses, renal failure
Calcium channel blockers Cognitive decline ...
Older patients are especially susceptible to drug-induced cognitive impairment. They are more likely to be taking multiple drugs, to have higher blood levels of those drugs because of renal or hepatic dysfunction, and to have pre-existing cognitive problems that make it difficult to detect the role of drugs causing new symptoms or making old ones worse.
In Brief: Prevention of Meningococcal B Disease
The Medical Letter on Drugs and Therapeutics • Dec 09, 2013 (Issue 1431)
Practices (ACIP). MMWR Recomm Rep 2013;
62(RR-2):1.
Rifampin vaccines 4CMenB antibacterials Bexsero ...
An outbreak (8 cases to date) of meningococcal disease at Princeton University caused by Neisseria meningitidis serogroup B has led the FDA and CDC to permit importation and investigational use (at Princeton University only) of a meningococcus B vaccine (4CMenB; Bexsero – Novartis) that has not been approved in the US. Bexsero has been approved for use in the European Union and in Australia.THE VACCINE — Until recently, no serogroup B vaccine was widely available because the polysaccharide capsule of the B serogroup, unlike those of the other main meningococcal serogroups (A, C, Y, and...
In Brief: More Fluoroquinolone Warnings
The Medical Letter on Drugs and Therapeutics • Aug 13, 2018 (Issue 1553)
of all systemic
fluoroquinolone antibiotics to strengthen warnings about
the risk of severe hypoglycemia ...
The FDA has required changes in the labeling of all systemic fluoroquinolone antibiotics to strengthen warnings about the risk of severe hypoglycemia and mental health effects associated with their use.1An FDA review identified 67 cases of hypoglycemic coma associated with fluoroquinolone use, 22 of which resulted in death or disability. Most cases occurred in patients with risk factors such as diabetes (especially those taking a sulfonylurea), older age, or renal insufficiency.1 In observational studies in older adults and patients with diabetes, fluoroquinolones have been associated with...
Elderberry for Influenza
The Medical Letter on Drugs and Therapeutics • Feb 25, 2019 (Issue 1566)
extract against clinically-relevant human respiratory
bacterial pathogens and influenza A and B viruses ...
Patients may ask about taking elderberry for prevention
and treatment of influenza. Products containing
elderberry are promoted for relief of cold and flu
symptoms and as an immune system booster.
Clarithromycin and Azithromycin
The Medical Letter on Drugs and Therapeutics • May 15, 1992 (Issue 870)
(Zithromax − Pfizer), two macrolide antibiotics chemically related to erythromycin, have been approved ...
Clarithromycin (Biaxin - Abbott) and azithromycin (Zithromax - Pfizer), two macrolide antibiotics chemically related to erythromycin, have been approved by the US Food and Drug Administration for treatment of respiratory, skin, and skin structure infections. Azithromycin has also been approved for treatment of nongonococcal urethritis and cervicitis caused by Chlamydia trachomatis.
Fitusiran (Qfitlia) for Hemophilia A and B
The Medical Letter on Drugs and Therapeutics • Jul 07, 2025 (Issue 1732)
with hemophilia A or B with and without inhibitors.
▶ Adverse Effects: Most common were bacterial and viral ...
Fitusiran (Qfitlia – Sanofi), a subcutaneously injected,
antithrombin-directed, small interfering ribonucleic
acid (siRNA), has been approved by the FDA for routine
prophylaxis to prevent or reduce the frequency of
bleeding episodes in patients ≥12 years old who have
hemophilia A with or without factor VIII inhibitors or
hemophilia B with or without factor IX inhibitors. It
is the first antithrombin-lowering therapy to become
available in the US for treatment of hemophilia.
Med Lett Drugs Ther. 2025 Jul 7;67(1732):110-1 doi:10.58347/tml.2025.1732c | Show Introduction Hide Introduction
Primary Prevention of Ulcers in Patients Taking Aspirin or NSAIDs
The Medical Letter on Drugs and Therapeutics • Mar 08, 2010 (Issue 1333)
-2769
antacids, the prostaglandin misoprostol (Cytotec,
and others), and antibiotics to eradicate H ...
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are common causes of peptic ulcer disease. Patients infected with Helicobacter pylori who take aspirin or another NSAID have an especially high risk. Drugs that have been tried for prevention of ulcers in patients taking NSAIDs including H2-receptor antagonists, proton pump inhibitors (PPIs), aluminum- or magnesium-containing antacids, the prostaglandin misoprostol (Cytotec, and others), and antibiotics to eradicate H. pylori.Click here to view the free full...
In Brief: Propofol Revisited
The Medical Letter on Drugs and Therapeutics • Oct 17, 2011 (Issue 1375)
on injection and bacterial contamination,
both related to its lipid emulsion formulation;
fospropofol ...
A reader has asked us to review the use of propofol (Diprivan, and others) as a sedative agent for brief procedures, such as colonoscopy.First marketed more than 20 years ago,1 propofol has a rapid onset of action (patients usually lose consciousness in less then one minute) and a short duration of action with a rapid recovery (3-5 minutes) that makes it highly suitable for brief ambulatory procedures. Propofol is now the most commonly used parenteral anesthetic in the US.2 The main problems with its use have been pain on injection and bacterial contamination, both related to its lipid...
